Madhur is Director of Real World Evidence and Market Access at Labcorp Drug Development.He has worked across global and regional roles in the pharmaceutical industry. He is a market access and pricing strategist with health economics and outcomes research background. His career has spanned across Europe and Asia working for various life science companies (including J&J, Lundbeck & LEO Pharma). He possesses experience with all major payers and health technology assessment (HTA) bodies across Europe, North America, Middle East and Asia Pacific.

Neeraj is Senior Manager, Health Economics & Outcomes Research at Novo Nordisk with over 15 years of corporate and academic experience in Healthcare Economics and Outcomes Research. Prior to joining Novo Nordisk, Neeraj worked as a Graduate Research Assistant at Purdue University and also held consulting roles at Concordas Informatics and had a brief stint at Pfizer.

Dr. Chureen T. Carter is currently the Senior Director, RWE Alliance Strategy and Research Operations Group Leader at Johnson & Johnson’s Janssen Scientific Affairs (JSA). She has responsibility for directing strategy development, alliance execution, and research with external healthcare stakeholders to establish a novel real-world evidence program for the Janssen North America Pharmaceuticals group. Dr. Carter has 16 years of experience in generating, disseminating, and communicating clinical and economic information. She received her Doctor of Pharmacy and Master of Science in Pharmacy Administration, and completed a Post-doctoral Outcomes Research Fellowship at Thomas Jefferson University in Philadelphia, PA.

Monika Szkultecka-Debek has a medical background and is post graduated in Health Economics.With has twenty years of experience in the pharmaceutical industry she has been working in Roche since 2000 on different functions. Initially her focus was clinical trials, followed by pharmacoeconomics activities. For several years she was implementing Health Economics in CEMAI region. Since 2013 she is part of Region Europe Pricing and Market Access Team, initially as Market Access Leader for CEE and from 2014 responsible for payer Real World Evidence activities focused on market access needs.